Robin Neubauer
Moffitt Cancer Center(US)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Hemodynamic Monitoring and Therapy, Genital Health and Disease, Heart Rate Variability and Autonomic Control, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Most-Cited Works
- → Endovascular Ultrasound Renal Denervation to Treat Hypertension(2023)168 cited
- → Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients(2017)85 cited
- → Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program(2023)34 cited
- → Pilot Study of Organ Preservation Multimodality Therapy for Locally Advanced Resectable Oropharyngeal Carcinoma(2000)14 cited
- → Numerically simulated cardiac exposure to electric current densities induced by TASER X-26 pulses in adult men(2010)7 cited
- → A phase 2 study of the combination dostarlimab with niraparib in patients with penile carcinoma that has progressed following chemotherapy.(2024)4 cited
- → A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis(2018)1 cited
- → Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma(2025)1 cited
- → A phase II trial of dostarlimab and niraparib combination therapy in patients with stage III-IV recurrent or refractory penile cancer.(2025)
- → SAT0328 An open-label study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis(2017)